![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](nc2082contents.gif)
Acta Cryst. (2008). E64, m248 [ doi:10.1107/S1600536807067281 ]
-3-(1H-benzimidazol-2-yl)[2,6-2H2]pyridine N-oxide]Abstract: In the crystal structure of the title compound, [ZnBr2(C12H7D2N3O)]n, the Zn atoms are coordinated by two Br atoms and by one N atom and one O atom of two symmetry-related 3-(1H-benzimidazol-2-yl)[2,6-2H2]pyridine N-oxide ligands in a slightly distorted tetrahedral geometry. The ZnBr2 units are connected by the organic ligands into chains.
Online 21 December 2007
Copyright © International Union of Crystallography
IUCr Webmaster